Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience

被引：0
作者：
Naoko Ishida
Kazuhiro Araki
Takehiko Sakai
Kokoro Kobayashi
Takayuki Kobayashi
Ippei Fukada
Mitsuchika Hosoda
Mitsugu Yamamoto
Kazuomi Ichinokawa
Shunji Takahashi
Takuji Iwase
Yoshinori Ito
Hiroko Yamashita
机构：
[1] Hokkaido University Hospital,Breast Surgery
[2] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Breast Medical Oncology
[3] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Surgical Oncology, Breast Oncology Center
[4] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Medical Oncology
来源：
Breast Cancer | 2016年 / 23卷
关键词：
Fulvestrant; Metastatic breast cancer; Advanced breast cancer; Postmenopausal; Endocrine therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：617 / 623
页数：6
相关论文
共 50 条
[31]   Prolonged time to progression with fulvestrant for metastatic breast cancer [J].
Celso A. L. Mello ;
Ludmilla T. D. Chinen ;
Samantha Cabral Severino da Silva ;
Carolina do Nascimento Matias ;
Carlos Frederico Benevides ;
Daniel Luiz Gimenes ;
Marcello F. Fanelli .
Medical Oncology, 2011, 28 :416-419
[32]   Fulvestrant in postmenopausal women with locally advanced or metastatic breast cancer that has progressed on prior endocrine therapy: a guide [J].
Lyseng-Williamson K.A. .
Drugs & Therapy Perspectives, 2015, 31 (10) :323-328
[33]   Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis [J].
Wang, Jiayu ;
Xu, Binghe ;
Wang, Wenna ;
Zhai, Xiaoyu ;
Chen, Xuelian .
BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (03) :535-544
[34]   Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant. Results from a real word setting [J].
Pizzuti, Laura ;
Natoli, Clara ;
Gamucci, Teresa ;
Mauri, Mariella ;
Sergi, Domenico ;
Di Lauro, Luigi ;
Paoletti, Giancarlo ;
Ruggeri, Enzo ;
Iezzi, Laura ;
Sperduti, Isabella ;
Mentuccia, Lucia ;
Fabbri, Agnese ;
Maugeri-Sacca, Marcello ;
Moscetti, Luca ;
Barba, Maddalena ;
Vici, Patrizia .
ONCOTARGET, 2017, 8 (40) :69025-69037
[35]   Fulvestrant (Faslodex™) in advanced breast cancer:: clinical experience from a Belgian cooperative study [J].
Neven, Patrick ;
Paridaens, Robert ;
Pelgrims, Gino ;
Martens, Marc ;
Bols, Alain ;
Goeminne, Jean Charles ;
Vindevoghel, Anita ;
Demol, Jan ;
Stragier, Barbara ;
De Greve, Jacques ;
Fontaine, Christel ;
Van Den Weyngaert, Danielle ;
Becquart, Dominique ;
Borms, Marleen ;
Cocquyt, Veronique ;
Van den Broecke, Rudy ;
Selleslags, Jean ;
Awada, Ahmad ;
Dirix, Luc ;
Van Dam, Peter ;
Azerad, Marie Agnes ;
Vandenhoven, Guy ;
Christiaens, Marie Rose ;
Vergote, Ignace .
BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) :59-65
[36]   Fulvestrant (Faslodex™) in advanced breast cancer: clinical experience from a Belgian cooperative study [J].
Patrick Neven ;
Robert Paridaens ;
Gino Pelgrims ;
Marc Martens ;
Alain Bols ;
Jean Charles Goeminne ;
Anita Vindevoghel ;
Jan Demol ;
Barbara Stragier ;
Jacques De Greve ;
Christel Fontaine ;
Danielle Van Den Weyngaert ;
Dominique Becquart ;
Marleen Borms ;
Veronique Cocquyt ;
Rudy Van Den Broecke ;
Jean Selleslags ;
Ahmad Awada ;
Luc Dirix ;
Peter Van Dam ;
Marie Agnes Azerad ;
Guy Vandenhoven ;
Marie Rose Christiaens ;
Ignace Vergote .
Breast Cancer Research and Treatment, 2008, 109 :59-65
[37]   Fulvestrant - A review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy [J].
McKeage, K ;
Curran, MP ;
Plosker, GL .
DRUGS, 2004, 64 (06) :633-648
[38]   Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer [J].
Mehta, Rita S. ;
Barlow, William E. ;
Albain, Kathy S. ;
Vandenberg, Ted A. ;
Dakhil, Shaker R. ;
Tirumali, Nagendra R. ;
Lew, Danika L. ;
Hayes, Daniel F. ;
Gralow, Julie R. ;
Livingston, Robert B. ;
Hortobagyi, Gabriel N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05) :435-444
[39]   Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial [J].
Moscetti, Luca ;
Fabbri, Maria Agnese ;
Natoli, Clara ;
Vici, Patrizia ;
Gamucci, Teresa ;
Sperduti, Isabella ;
Iezzi, Laura ;
Iattoni, Elena ;
Pizzuti, Laura ;
Roma, Carmine ;
Vaccaro, Angela ;
D'Auria, Giuliana ;
Mauri, Mariella ;
Mentuccia, Lucia ;
Grassadonia, Antonino ;
Barba, Maddalena ;
Ruggeri, Enzo Maria .
ONCOTARGET, 2017, 8 (33) :54528-54536
[40]   Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer [J].
Bartsch, Rupert ;
Bago-Horvath, Zsuzsanna ;
Berghoff, Anna ;
DeVries, Catharina ;
Pluschnig, Ursula ;
Dubsky, Peter ;
Rudas, Margaretha ;
Mader, Robert M. ;
Rottenfusser, Andrea ;
Fitzal, Florian ;
Gnant, Michael ;
Zielinski, Christoph C. ;
Steger, Guenther G. .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) :1932-1938
12345